BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26523094)

  • 21. Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models.
    Penna F; Busquets S; Toledo M; Pin F; Massa D; López-Soriano FJ; Costelli P; Argilés JM
    J Lipid Res; 2013 Nov; 54(11):3045-51. PubMed ID: 23966665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.
    Penna F; Ballarò R; Martinez-Cristobal P; Sala D; Sebastian D; Busquets S; Muscaritoli M; Argilés JM; Costelli P; Zorzano A
    J Mol Biol; 2019 Jul; 431(15):2674-2686. PubMed ID: 31150737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells.
    Fukuda T; Sumi T; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Oncol; 2009 Jan; 34(1):61-7. PubMed ID: 19082478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila as a Model for Tumor-Induced Organ Wasting.
    Saavedra P; Perrimon N
    Adv Exp Med Biol; 2019; 1167():191-205. PubMed ID: 31520356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
    Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
    BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediators of cachexia in cancer patients.
    Argilés JM; López-Soriano FJ; Busquets S
    Nutrition; 2019 Oct; 66():11-15. PubMed ID: 31177056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer cachexia - adopting a systems wide approach.
    Sayers J; Skipworth RJ; Laird BJ
    Curr Opin Clin Nutr Metab Care; 2023 Jul; 26(4):393-398. PubMed ID: 37265093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complex liaison between cachexia and tumor burden (Review).
    De Lerma Barbaro A
    Oncol Rep; 2015 Oct; 34(4):1635-49. PubMed ID: 26239384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Adipokines in Cancer Cachexia.
    Mannelli M; Gamberi T; Magherini F; Fiaschi T
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
    Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
    J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
    Argilés JM; Anguera A; Stemmler B
    Clin Nutr; 2013 Jun; 32(3):319-24. PubMed ID: 23395103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexia.
    Shum AM; Fung DC; Corley SM; McGill MC; Bentley NL; Tan TC; Wilkins MR; Polly P
    Physiol Genomics; 2015 Dec; 47(12):588-99. PubMed ID: 26395599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
    Steffen BT; Lees SJ; Booth FW
    J Appl Physiol (1985); 2008 Dec; 105(6):1950-8. PubMed ID: 18801959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.
    Asp ML; Tian M; Kliewer KL; Belury MA
    Cancer Biol Ther; 2011 Dec; 12(11):957-65. PubMed ID: 22104958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
    Talbert EE; Guttridge DC
    Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.